Submitted on Friday 18th September 2015
Published on Tuesday 22nd September 2015
Current status: Closed
Closed: Tuesday 22nd March 2016
Signatures: 1,560
Reinstate bevacizumab (Avastin) for cervical cancer on the Cancer Drugs Fund
Fewer signatures
More signatures
Colours relate to the distribution of signatures across different constituencies and not to the absolute number.
Constituency boundaries are slightly simplified in order to minimise loading time. More detailed boundaries are shown on individual constituency pages.
3.144.90.108 Thu, 21 Nov 2024 20:05:00 +0000
